Physician profile
Bashar Nahab
NPI 1326414152
$5,526.77
in general payments reported to CMS, 2019-2025
12 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $538 · 2021: $1,603 · 2022: $464 · 2023: $484 · 2024: $818 · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,682 · Travel and Lodging: $1,039 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.87 |
| Travel and Lodging | $1,039.41 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $1,598.80 | 2024-2025 | |
| Boston Scientific Corporation | $1,355.34 | 2020-2023 | |
| Inari Medical, INC. | $869.18 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sirtex Medical INC | $511.75 | 2023-2025 | Sir-Spheres Microspheres |
| Medtronic Vascular, INC. | $342.81 | 2020 | |
| Medtronic, INC. | $272.59 | 2021-2023 | Emprint |
| Penumbra, INC. | $141.23 | 2021 | |
| Angiodynamics, INC. | $132.81 | 2025 | Alphavac |
| Advanced Critical Devices, INC. | $116.16 | 2025 | Vascular Products |
| Bard Peripheral Vascular, INC. | $93.00 | 2020 | |
| Ge Healthcare | $74.82 | 2024 | |
| Scientia Vascular | $18.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Nahab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.